Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 3Phase NA 1Phase 3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 20Gastrointestinal 20Gynecologic 4Thoracic 3Breast 3Other 2Dermatologic 2Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 220Head and Neck Neoplasms 172Carcinoma, Non-Small-Cell Lung 104Melanoma 63Neoplasms 56Colorectal Neoplasms 55Uterine Cervical Neoplasms 53Ovarian Neoplasms 50Stomach Neoplasms 48Neoplasm Metastasis 46Breast Neoplasms 46Triple Negative Breast Neoplasms 45Lung Neoplasms 44Carcinoma, Renal Cell 40Esophageal Neoplasms 37Nasopharyngeal Carcinoma 33Endometrial Neoplasms 33Pancreatic Neoplasms 32Thyroid Neoplasms 30Prostatic Neoplasms 26Carcinoma, Squamous Cell 26Sarcoma 25Colonic Neoplasms 24Urinary Bladder Neoplasms 23Small Cell Lung Carcinoma 23Oropharyngeal Neoplasms 23Carcinoma, Transitional Cell 23Carcinoma 22Salivary Gland Neoplasms 20Nasopharyngeal Neoplasms 20

Interventions

pexidartinib 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Gastrointestinal Stromal Tumors × Head & Neck × Clear all
NCT02452424 2020-03-05

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Daiichi Sankyo

Phase 1/2 Terminated
78 enrolled 19 charts
DermatologicGastrointestinalGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Ovarian Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡